@article{ec3010df9742417a8d5070dfff3e40e4,
title = "A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients",
keywords = "CPG ISLAND HYPERMETHYLATION, HIPPEL-LINDAU GENE, CARCINOMA, MUTATIONS, EXPRESSION, PROGNOSIS, INACTIVATION, NETHERLANDS, EVOLUTION, RECEPTOR",
author = "{van Vlodrop}, {Iris J. H.} and Joosten, {Sophie C.} and {De Meyer}, Tim and Smits, {Kim M.} and {Van Neste}, Leander and Veerle Melotte and Baldewijns, {Marcella M. L. L.} and Schouten, {Leo J.} and {van den Brandt}, {Piet A.} and Jana Jeschke and Yi, {Joo Mi} and Schuebel, {Kornel E.} and Nita Ahuja and Herman, {James G.} and Aarts, {Maureen J.} and Bosman, {Fred T.} and {Van Criekinge}, Wim and {van Engeland}, Manon",
year = "2017",
month = apr,
day = "15",
doi = "10.1158/1078-0432.CCR-16-1236",
language = "English",
volume = "23",
pages = "2006--2018",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "8",
}